St. Jude Medical

The Little Canada-based company develops medical technology, products and services that treat cardiac, neurological and chronic pain patients.

August 25
St. Jude Medical, with its corporate headquarters in Little Canada, is the second-largest medical device maker based in the Twin Cities.

St. Jude stock tumbles as report questions company's cybersecurity

A short seller says half of the company's revenue could be at stake; St. Jude said the claims are untrue.
July 20
St. Jude Medical, with its corporate headquarters in Little Canada, is the second-largest medical device maker based in the Twin Cities.

With acquisition pending, St. Jude Medical's rivals 'licking their lips,' analyst says

Its largest division has already taken a hit, and the complexity of a merger hasn't started yet.
July 13

Feds taking a close look at Abbott's proposed purchase of St. Jude Medical

Regulators want a closer look, but the two expect it finalized by year's end.
May 24

St. Jude Medical's stroke prevention device recommended for FDA approval

FDA-convened panel said stroke-prevention product appears safe and effective.
April 29

Abbott is counting on growth turnaround at St. Jude Medical

New products that are not yet approved by regulators are key to making the deal work.
April 28
St. Jude Medical, with its corporate headquarters in Little Canada, is the second-largest medical device maker based in the Twin Cities.

Abbott's $30 billion deal for St. Jude Medical not seen as job killer

The shareholders of the last giant medtech company based in Minnesota are being rewarded with a giant premium.
April 20

St. Jude Medical beats analysts' earnings estimates for quarter

The company's stock jumped as St. Jude offset woes in heart devices.
February 18

Noting unknowns, FDA panel urges scrutiny of tiny pacemakers

Tiny pacemakers, some Minnesota-made, will undergo deep scrutiny.
February 17

St. Jude Medical gets FDA approval for new heart-device technology

Company hopes its MultiPoint Pacing technology will become the next standard for care.
February 13

FDA panel to determine how to best test new pacemakers from St. Jude, Medtronic

High hopes are riding on a new generation of tiny pacemakers, but the Minnesota med-tech companies that make them will be working this week to convince medical experts that the devices can be safely tested and eventually extracted from patients' hearts.
February 6

Medical device makers face challenge of falling prices

At a time when U.S. health care costs have been rising faster than inflation, the prices for many medical devices have been dropping.
January 27

St. Jude earnings beat forecast, but revenue falls short

The company is facing new competition in pacemakers, one of its biggest products.
January 22

St. Jude Medical issues advisory on Optisure leads

Problem with defibrillation leads could cause serious health issues.
January 13

St. Jude says earnings within estimates despite lower sales of heart-rhythm devices

Sales in its largest division, heart-rhythm devices, fell 10 percent in quarter to $580M.
October 24, 2015

Schafer: Outgoing St. Jude's CEO Dan Starks was hands-on in his approach

Dan Starks, who will step aside at the end of the year as CEO of St. Jude Medical, doesn't spend his time the way some CEOs of other big companies he's observed do, being what he called "administrators."
October 5, 2015

St. Jude looking at heart valves after journal raises questions

After clotting reports, St. Jude will give design more study.
October 2, 2015

FDA warns St. Jude on manufacturing 'non-conformities' at Atlanta plant

A warning letter raised no safety issues and the plant continues to operate.
September 16, 2015

Former St. Jude exec charged with theft of trade secrets, cash

Bryan Szweda accused of stealing trade secrets, $117,000 in cash.
August 6, 2015

FDA cites increased risk from heart pumps made by St. Jude acquisition target

Thoratec's heart pump has had trouble with blood clots.
July 25, 2015
The deal announcement came as St. Jude reported a decline in quarterly earnings Wednesday, but it beat earnings forecasts.

St. Jude sees good outlook for Thoratec HeartMate 3

St. Jude Medical is banking on a positive forecast after the company announced plans last week to buy Thoratec Corp. in a $3.4 billion deal that would be St. Jude's biggest corporate acquisition ever.
July 22, 2015

St. Jude Medical to buy Calif. heart-device firm for $3.4B

Little Canada medical device maker St. Jude Medical announced a definitive agreement Wednesday to acquire California heart-device firm Thoratec for $3.4 billion. The deal, the largest ever for St. Jude, is expected to close by the end of the year.
July 21, 2015

St. Jude Medical reportedly in talks for California heart device company

Minnesota firm reportedly negotiating a $3 billion purchase of Thoratec Corp.
July 10, 2015

Devicemakers from Minnesota paid hospitals, docs $211M in 2014

National data show state firms' payments to doctors and hospitals.
June 4, 2015

New St. Jude device treats chronic pain using iPod

Bluetooth technology allows patients to control treatment.
May 23, 2015

St. Jude facing safety questions regarding tiny new pacemaker

Physicians, and some stock analysts, are closely watching the safety profile of tiny novel pacemakers like the Nano­stim in ongoing studies. Implants of the device have been halted in Europe after several became dislodged.